Recent advances on endogenous gasotransmitters in inflammatory dermatological disorders
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Advanced Research
- Vol. 38, 261-274
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21772131, 81773685, 81872535)
- China Postdoctoral Science Foundation (2020M673295, 2020T130273)
- Sichuan University (2019HXCX10, ZYJC18032, ZYYC21002)
- West China Hospital, Sichuan University
This publication has 181 references indexed in Scilit:
- Clinical study of isosorbide mononitrate treatment for angina pectoris in coronary heart diseaseExperimental and Therapeutic Medicine, 2013
- The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailabilityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory PharmaceuticalsACS Medicinal Chemistry Letters, 2012
- PLP-dependent H2S biogenesisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- Keratinocyte Apoptosis in Epidermal Remodeling and Clearance of Psoriasis Induced by UV RadiationJournal of Investigative Dermatology, 2011
- Hydrogen sulfide is an endogenous stimulator of angiogenesisProceedings of the National Academy of Sciences, 2009
- Signaling by GasotransmittersScience Signaling, 2009
- Relative sensitivity of soluble guanylate cyclase and mitochondrial respiration to endogenous nitric oxide at physiological oxygen concentrationBiochemical Journal, 2007
- Nitric Oxide Levels in Patients with Psoriasis Treated with MethotrexateMediators of Inflammation, 2006